Equalize Health announces partnership with souther...
A partnership to develop and launch a mother-centered, “blood loss monitoring device” to detect PPH, the leading cause of maternal death globally.
The Pulse - our central platform for latest news and perspectives.
Consider it your lifeline for internal developments at Equalize Health and important global health and innovation news.
A partnership to develop and launch a mother-centered, “blood loss monitoring device” to detect PPH, the leading cause of maternal death globally.
We offer our admiration and heartfelt thanks to Krista Donaldson, as she steps down from her role as CEO of Equalize Health. I represent Equalize Health’s Board of Directors when I say, we are grateful for Krista’s visionary leadership that has brought significant change to the lives of more than one million patients around the world.
After 13 years of leading this amazing organization from its early days in “the dark basement” (it wasn’t really) of an old house in Palo Alto to our multi-continent thriving organization that we are today, it is time for me to make room for a new CEO with diverse and fresh ideas.
The $15M Catalytic Fund will provide healthcare and world-class medical technologies to five million patients by 2025 and help end the leading causes of preventable maternal and newborn deaths.
Equalize Health CEO, Krista Donaldson, is a 2021 Elevate Prize winner.